Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#239 of 589

Graig Suvannavejh

Mizuho · Equity Research Analyst
ProvisionalRating since 2022No new ratings since Nov 2025

Analyst rating accuracy & track record

Graig Suvannavejh is an equity research analyst at Mizuho. Quantellect has scored 22 of their stock calls across 13 companies. Their picks beat their sector 40% of the time over the next 12 months, and their price targets were reached 44% of the time within a year.

Win % vs sector
40%
PT Hit % (12mo)
44%
Avg sector-excess
−2.7%
Scored calls
22
Tickers
13
Tier
Provisional

Track record

Quantellect has scored 22 of Graig Suvannavejh's stock calls across 13 companies, dating back to 2022. Their rated stocks beat their own sector 40% of the time over the next 12 months. On a typical call, a Suvannavejh pick returned −2.7% more than its sector over the following year.

Of the scored calls, 22 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
IDYAIdeaya Biosciences Inc
Buy$46.00Nov 2025−22.3%Miss
HRMYHarmony Biosciences Holdings
Buy$39.00Nov 2025−22.2%Hit
AXSMAxsome Therapeutics Inc
Buy$202.00Nov 2025−31.7%Hit
HRMYHarmony Biosciences Holdings
Buy$35.00Sep 2025+22.9%Hit
IDYAIdeaya Biosciences Inc
Buy$44.00Sep 2025+30.9%Miss
KALAKala Pharmaceuticals Inc
Buy$30.00Sep 2025−122.1%Miss
ALECAlector Inc
Buy$3.50Jul 2025−31.6%Miss
NMRANeumora Therapeutics, Inc.
Buy$5.00Jul 2025−29.9%Miss
IMRXImmuneering Corp
Buy$10.00Jun 2025+58.1%Hit
CRVSCorvus Pharmaceuticals Inc
Buy$11.00May 2025+222.0%Hit
EYPTEyePoint, Inc
Buy$26.00May 2025+81.4%Miss
HRMYHarmony Biosciences Holdings
Buy$48.00May 2025−25.2%Miss
AMLXAmylyx Pharmaceuticals Inc
Buy$8.00May 2025+193.2%Hit
AMLXAmylyx Pharmaceuticals Inc
Buy$7.00Apr 2025+379.4%Hit
HRMYHarmony Biosciences Holdings
Buy$44.00Mar 2025−21.0%Miss
CRBPCorbus Pharmaceuticals Holding
Buy$74.00Sep 2024−29.2%Miss
IMTXImmatics NV
Buy$16.00May 2024−49.2%Miss
IMRXImmuneering Corp
Buy$8.00Apr 2024−36.8%Miss
ALECAlector Inc
Buy$9.00Nov 2023−35.3%Miss
TERNTerns Pharmaceuticals Inc
Buy$16.00Jun 2023−61.4%Miss
IMTXImmatics NV
Buy$12.00Mar 2023+46.7%Hit
AXSMAxsome Therapeutics Inc
Buy$76.00Sep 2022+29.3%Hit
Prev1Next
Go to

Graig Suvannavejh: analyst track record FAQ

Is Graig Suvannavejh a good stock analyst?

Yes, by track record. Graig Suvannavejh ranks number 239 of 589 of the analysts Quantellect scores, with an Analyst Score of 42 out of 100. Past results do not guarantee future ones.

What is Graig Suvannavejh's win rate?

Graig Suvannavejh's win rate is 40%. Across 22 scored calls, their rated stocks beat their sector 40% of the time over the next 12 months. On a typical call they returned −2.7% more than the sector.

What stocks and sectors does Graig Suvannavejh cover?

Graig Suvannavejh covers 13 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Graig Suvannavejh's price targets accurate?

Graig Suvannavejh's price targets are reached within 12 months 44% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Graig Suvannavejh's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Graig Suvannavejh rank among Wall Street analysts?

Graig Suvannavejh ranks number 239 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.